Notes to applicants for marketing authorizations on the production and quality control of medicinal products derived by recombinant DNA technology. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy.
D000818:Animals; D001688:Biological Products / Q000096:biosynthesis / Q000592:standards*; D001709:Biotechnology / Q000592:standards*; D003001:Cloning, Molecular; D004274:DNA, Recombinant; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry; D015870:Gene Expression; D005822:Genetic Vectors; D011786:Quality Control
D001688:Biological Products; D004274:DNA, Recombinant